Researchers have found a link between chemotherapy-induced changes to gut bacteria and the unhealthy weight gain seen in breast cancer patients, pointing the way to potentially help survivors avoid obesity-related illness ...
Jul 13, 2023
0
1
Strongest adherence to cancer prevention lifestyle recommendations is associated with reductions in disease recurrence and mortality among patients with high-risk breast cancer, according to a study published online May 4 ...
May 5, 2023
0
3
Researchers, led by Pennington Biomedical Research Center's Dr. Justin Brown, have found that physical activity can prevent, and not just delay, cancer recurrence in patients previously treated for colon cancer.
Mar 21, 2023
0
2
The best treatment for a genetically driven form of lung cancer continues to show lasting benefits, a new clinical trial update shows.
Feb 6, 2023
0
2
A multi-center analysis of patients with invasive lobular carcinoma, or ILC—the second most common histological subtype of invasive breast cancer in the U.S.—showed that, despite its prevalence, ILC is detected later ...
Oct 14, 2022
0
41
Physical activity may be associated with improved outcomes for patients undergoing postoperative treatment for Stage III colon cancer.
Sep 8, 2022
0
2
Using an artificial intelligence (AI) tool that emulates how humans visualize and is trained to recognize and classify images, investigators constructed a model that predicts the postoperative recurrence of Crohn disease ...
May 10, 2022
0
14
An immunotherapy drug called pembrolizumab has been shown to significantly reduce disease recurrence in patients with the most aggressive type of breast cancer, according to results from a phase III clinical trial led by ...
Feb 10, 2022
0
13
Among younger adults who had a previous stroke or a transient ischemic attack (TIA) and were later hospitalized for any cause, recurrent stroke was far more likely among patients with cannabis use disorder, according to preliminary ...
Feb 3, 2022
0
6
Tagrisso (osimertinib) received approval as an adjuvant treatment for patients with non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, the U.S. Food and Drug ...
Dec 23, 2020
0
5
